Steeg PS - Search Results

1

Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models.

Varticovski L, Hollingshead MG, Robles AI, Wu X, Cherry J, Munroe DJ, Lukes L, Anver MR, Carter JP, Borgel SD, Stotler H, Bonomi CA, Nunez NP, Hursting SD, Qiao W, Deng CX, Green JE, Hunter KW, Merlino G, Steeg PS, Wakefield LM, Barrett JC. Varticovski L, et al. Among authors: steeg ps. Clin Cancer Res. 2007 Apr 1;13(7):2168-77. doi: 10.1158/1078-0432.CCR-06-0918. Clin Cancer Res. 2007. PMID: 17404101

2

Altered expression of NM23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis.

Steeg PS, Bevilacqua G, Pozzatti R, Liotta LA, Sobel ME. Steeg PS, et al. Cancer Res. 1988 Nov 15;48(22):6550-4. Cancer Res. 1988. PMID: 2460224

3

Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential.

Bevilacqua G, Sobel ME, Liotta LA, Steeg PS. Bevilacqua G, et al. Among authors: steeg ps. Cancer Res. 1989 Sep 15;49(18):5185-90. Cancer Res. 1989. PMID: 2475243

4

Nm23 and breast cancer metastasis.

Steeg PS, de la Rosa A, Flatow U, MacDonald NJ, Benedict M, Leone A. Steeg PS, et al. Breast Cancer Res Treat. 1993;25(2):175-87. doi: 10.1007/BF00662142. Breast Cancer Res Treat. 1993. PMID: 8347849 Review.

5

Identification of compounds with preferential inhibitory activity against low-Nm23-expressing human breast carcinoma and melanoma cell lines.

Freije JM, Lawrence JA, Hollingshead MG, De la Rosa A, Narayanan V, Grever M, Sausville EA, Paull K, Steeg PS. Freije JM, et al. Among authors: steeg ps. Nat Med. 1997 Apr;3(4):395-401. doi: 10.1038/nm0497-395. Nat Med. 1997. PMID: 9095172

6

Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition.

Hartsough MT, Clare SE, Mair M, Elkahloun AG, Sgroi D, Osborne CK, Clark G, Steeg PS. Hartsough MT, et al. Among authors: steeg ps. Cancer Res. 2001 Mar 1;61(5):2320-7. Cancer Res. 2001. PMID: 11280805

7

Metastasis suppressor genes: basic biology and potential clinical use.

Steeg PS, Ouatas T, Halverson D, Palmieri D, Salerno M. Steeg PS, et al. Clin Breast Cancer. 2003 Apr;4(1):51-62. doi: 10.3816/cbc.2003.n.012. Clin Breast Cancer. 2003. PMID: 12744759 Review.

8

Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds.

Ouatas T, Halverson D, Steeg PS. Ouatas T, et al. Among authors: steeg ps. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3763-72. Clin Cancer Res. 2003. PMID: 14506169

9

Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer.

Palmieri D, Halverson DO, Ouatas T, Horak CE, Salerno M, Johnson J, Figg WD, Hollingshead M, Hursting S, Berrigan D, Steinberg SM, Merino MJ, Steeg PS. Palmieri D, et al. Among authors: steeg ps. J Natl Cancer Inst. 2005 May 4;97(9):632-42. doi: 10.1093/jnci/dji111. J Natl Cancer Inst. 2005. PMID: 15870434

10

c-Met ectodomain shedding rate correlates with malignant potential.

Athauda G, Giubellino A, Coleman JA, Horak C, Steeg PS, Lee MJ, Trepel J, Wimberly J, Sun J, Coxon A, Burgess TL, Bottaro DP. Athauda G, et al. Among authors: steeg ps. Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4154-62. doi: 10.1158/1078-0432.CCR-06-0250. Clin Cancer Res. 2006. PMID: 16857786

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

233 results

Search Page

Filters